In Vitro and In Vivo Efficiency of Extenders Added to Thawed Stallion Semen.

BACKGROUND: Addition of extenders to thawed semen could improve fertility. OBJECTIVE: To determine the efficiency of extenders to increase viability of thawed semen, measured by sperm parameters in vitro and pregnancy rates after artificial insemination (AI). MATERIALS AND METHODS: Sperm motility and acrosin activity were measured during a thermoresistance test (TRT). RESULTS: Progressive motility decreased (P<0.05) after 30 min in thawing semen treated with saline solution (SS) and only after 60 min with Tyrode's solution (TS) or freezing diluent (FD). The total motility decreased (P<0.05) after 60 min in thawed semen treated with SS, and after 90 min in thawed semen containing TS or FD. The acrosin activity decreased (P<0.05) after 60 min during the TRT, but there was no difference among treatments throughout the TRT. The pregnancy rates were similar among thawed-semen supplemented with SS, TS or FD. CONCLUSION: The extenders neither improve sperm parameters nor enhance AI results.

Comparison of different protocols used to induce and synchronize estrus cycle of Saanen goats.

The objective of the present study was to determine the efficiency of different protocols in inducing and synchronizing the estrus cycle of Saanen goats by using new or reused synchro-mate-B (SMB) and controlled internal drug release (CIDR) in combination with either equine chorionic gonadotrophin (eCG) or cloprostenol. Female goats (n=120) were divided at random into six groups of 20 animals each. In the T1-SMB group, the females were injected intramuscularly (i.m.) with 2.5mg estradiol valerate+1.5mg norgestomet and received a subcutaneous ear implant containing 2.0mg of norgestomet for 9 days. On the day of implant removal, the animals received 100IU of eCG and 0.05mg of cloprostenol. In the T2-SMB group, the animals were identically treated, except that the ear implant they received had been previously used in cattle. In the T3-SMB group, the treatment was identical to that for T1-SMB, but eCG was not administered. In the T1-CIDR group, the animals were treated for 9 days with an intravaginal device inpregnated with 0.3g of progesterone and injected i.m. with 100IU of eCG and 0.05mg of cloprostenol on the day of implant removal. The animals of the T2-CIDR group were treated like those of the T1-CIDR group, except that the intravaginal implant they received had been previously used in goats. The animals of the T3-CIDR group were treated like those of the T1-CIDR group, but did not receive eCG. The percentages of estrus and fertility were 100/80% (T1-SMB), 90/80% (T2-SMB), 75/75% (T3-SMB), 100/95% (T1-CIDR), 100/100% (T2-CIDR) and 70/65% (T3-CIDR), respectively, with the results for both parameters being lower (P